Skip to main content
Quest Diagnostics

Predictors of Lack of Glycemic Control in Persons With Type 2 Diabetes

Predictors of Lack of Glycemic Control in Persons With Type 2 Diabetes

Authors: Louie JZ, Shiffman D, Rowland CM, Kenyon NS, Bernal-Mizrachi E, McPhaul MJ, Garg R

Citation: Clin Diabetes Endocrinol. 2024 Jan 25;10(1):2. doi: 10.1186/s40842-023-00160-7.

Specialties: Endocrinology, Cardiovascular disease, Cardiology,

Related content

On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting
Conference Presentation
Assessment of NAFLD Burden in an Employee Wellness Program Among Non-obese Patients Without Evident Metabolic Abnormalities
Publication
How much glucose is in Sweet Cheeks oral glucose gel
On-Demand Webinar
Biomarker Testing as a Preventive Health Strategy
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.